Dianthus Therapeutics DNTH Change in AR
Change in AR at other companies
Other financials
Where this comes from
Reported directly by Dianthus Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.
The official record: Dianthus Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dianthus Therapeutics's change in ar.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Dianthus Therapeutics's change in AR?
- Dianthus Therapeutics (DNTH) reported change in AR of $1.18M in Q1 2026.
- How has Dianthus Therapeutics's change in AR changed year-over-year?
- Dianthus Therapeutics's change in AR increased by 17.8% year-over-year, from $1M to $1.18M.
- What does change in AR mean?
- Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.